222 related articles for article (PubMed ID: 15748148)
1. Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist.
Wang HL; Hsu CY; Huang PC; Kuo YL; Li AH; Yeh TH; Tso AS; Chen YL
J Neurochem; 2005 Mar; 92(6):1285-94. PubMed ID: 15748148
[TBL] [Abstract][Full Text] [Related]
2. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
Mandyam CD; Thakker DR; Standifer KM
J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
[TBL] [Abstract][Full Text] [Related]
3. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
Wang Q; Traynor JR
Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
[TBL] [Abstract][Full Text] [Related]
4. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
[TBL] [Abstract][Full Text] [Related]
5. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
6. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
7. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
Li AH; Wang HL
J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
[TBL] [Abstract][Full Text] [Related]
9. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
[TBL] [Abstract][Full Text] [Related]
10. Two C-terminal amino acids, Ser(334) and Ser(335), are required for homologous desensitization and agonist-induced phosphorylation of opioid receptor-like 1 receptors.
Wang HL; Kuo YL; Hsu CY; Huang PC; Li AH; Chou AH; Yeh TH; Chen YL
Cell Signal; 2006 May; 18(5):670-8. PubMed ID: 16019191
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
12. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
Thakker DR; Standifer KM
Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
[TBL] [Abstract][Full Text] [Related]
13. Glycinergic inputs to cardiac vagal neurons in the nucleus ambiguus are inhibited by nociceptin and mu-selective opioids.
Venkatesan P; Baxi S; Evans C; Neff R; Wang X; Mendelowitz D
J Neurophysiol; 2003 Sep; 90(3):1581-8. PubMed ID: 12761284
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.
Pfeiffer M; Koch T; Schröder H; Laugsch M; Höllt V; Schulz S
J Biol Chem; 2002 May; 277(22):19762-72. PubMed ID: 11896051
[TBL] [Abstract][Full Text] [Related]
15. Antagonizing effect of protein kinase C activation on the mu-opioid agonist-induced inhibition of high voltage-activated calcium current in rat periaqueductal gray neuron.
Cho YW; Han SH; Min BI; Rhee JS; Akaike N
Brain Res; 2001 Oct; 916(1-2):61-9. PubMed ID: 11597591
[TBL] [Abstract][Full Text] [Related]
16. [Primary investigation on heterodimerization of kappa-opioid receptor and ORL1 receptor].
Wen Q; Yan LD; Li YL; Gong ZH
Yao Xue Xue Bao; 2011 Sep; 46(9):1078-83. PubMed ID: 22121778
[TBL] [Abstract][Full Text] [Related]
17. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
Mandyam CD; Altememi GF; Standifer KM
Eur J Pharmacol; 2000 Aug; 402(1-2):R1-37. PubMed ID: 10940375
[TBL] [Abstract][Full Text] [Related]
18. Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment.
Duraffourd C; Kumala E; Anselmi L; Brecha NC; Sternini C
PLoS One; 2014; 9(10):e110230. PubMed ID: 25302800
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine activates mu and opioid receptor like-1 receptors simultaneously, but the analgesic effect is mainly mediated by mu receptor activation in the rat formalin test.
Yamamoto T; Shono K; Tanabe S
J Pharmacol Exp Ther; 2006 Jul; 318(1):206-13. PubMed ID: 16565164
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
Wang Q; Liu-Chen LY; Traynor JR
J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
